Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2016 Oct 6;115(9):e15. doi: 10.1038/bjc.2016.330

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia

Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfeldt, Bjørn Straume
PMCID: PMC5117800  PMID: 27711084

Correction to: British Journal of Cancer (2016) 115, 725–730; doi:10.1038/bjc.2016.247

Upon publication of the above paper in the British Journal of Cancer, the authors identified an error in the spelling of one of their names. The authors would like to apologise for this mistake. Christer Borgfeldt appears correctly in the author list above.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES